NCT03792906View on ClinicalTrials.gov

Comparison of Two Norepinephrine Bolus Doses for Management of Post-spinal Hypotension During Cesarean Delivery

PHASE4CompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

January 18, 2019

Primary Completion Date

April 25, 2019

Study Completion Date

May 1, 2019

Conditions
Cesarean Section ComplicationsSpinal Anesthetic Toxicity
Interventions
DRUG

Norepinephrine 6 mcg

An intravenous bolus of norepinephrine 6 mcg will be administered for management of maternal hypotension.

DRUG

Norepinephrine 10 mcg

An intravenous bolus of norepinephrine 10 mcg will be administered for management of maternal hypotension.

DRUG

Norepinephrine infusion

Prophylactic norepinephrine infusion will be started after subarachnoid block.

DRUG

Bupivacaine hydrochloride

Subarachnoid block will be performed using Bupivacaine hydrochloride (2.2 mL) in addition to fentanyl 25 mcg.

Trial Locations (1)

11432

Ahmed Mohamed Hasanin, Cairo

All Listed Sponsors
lead

Cairo University

OTHER

NCT03792906 - Comparison of Two Norepinephrine Bolus Doses for Management of Post-spinal Hypotension During Cesarean Delivery | Biotech Hunter | Biotech Hunter